Title : Knockdown of glyoxalase 1 mimics diabetic nephropathy in nondiabetic mice.

Pub. Date : 2014 Jan

PMID : 24062246






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Overexpression of the enzyme glyoxalase 1 (Glo1), which prevents posttranslational modification of proteins by the glycolysis-derived alpha-oxoaldehyde, methylglyoxal (MG), prevents hyperglycemia-induced oxidative stress in cultured cells and model organisms. Pyruvaldehyde glyoxalase 1 Mus musculus
2 Overexpression of the enzyme glyoxalase 1 (Glo1), which prevents posttranslational modification of proteins by the glycolysis-derived alpha-oxoaldehyde, methylglyoxal (MG), prevents hyperglycemia-induced oxidative stress in cultured cells and model organisms. Pyruvaldehyde glyoxalase 1 Mus musculus
3 Overexpression of the enzyme glyoxalase 1 (Glo1), which prevents posttranslational modification of proteins by the glycolysis-derived alpha-oxoaldehyde, methylglyoxal (MG), prevents hyperglycemia-induced oxidative stress in cultured cells and model organisms. Pyruvaldehyde glyoxalase 1 Mus musculus
4 Overexpression of the enzyme glyoxalase 1 (Glo1), which prevents posttranslational modification of proteins by the glycolysis-derived alpha-oxoaldehyde, methylglyoxal (MG), prevents hyperglycemia-induced oxidative stress in cultured cells and model organisms. Pyruvaldehyde glyoxalase 1 Mus musculus
5 In this study, we show that in nondiabetic mice, knockdown of Glo1 increases to diabetic levels both MG modification of glomerular proteins and oxidative stress, causing alterations in kidney morphology indistinguishable from those caused by diabetes. Pyruvaldehyde glyoxalase 1 Mus musculus
6 We also show that in diabetic mice, Glo1 overexpression completely prevents diabetes-induced increases in MG modification of glomerular proteins, increased oxidative stress, and the development of diabetic kidney pathology, despite unchanged levels of diabetic hyperglycemia. Pyruvaldehyde glyoxalase 1 Mus musculus